Related Experiment Videos
"Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty
E Garbarz1, B Farah, A Vuillemenot
1Cardiology Department, Tenon Hospital, Paris, France.
The American Journal of Cardiology
|October 7, 1998
Abstract:
We studied the in-hospital outcome of 138 consecutive patients who received abciximab as a "rescue" intervention for complicated coronary angioplasty in a high-risk clinical setting. "Rescue" treatment with abciximab was associated with clinical and angiographic success rates of 83% and 84%, respectively, whereas the risk of bleeding was higher in patients of low body weight.